Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Exercise or conversion Chief Executive Officer acquired 33,000 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes General Counsel and Secretary gave up 4,741 shares (to pay taxes)
  9. 4 Shares withheld for taxes CBO & COO gave up 4,207 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 787 shares (to pay taxes)
  11. 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $138.52 ($3,462,926)
  12. 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $128.78 ($3,863,469)
  13. 4 Open-market sale Director sold 10,000 shares at an average $126.43 ($1,264,348)
  14. 4 Open-market sale President sold 25,000 shares at $165.00 ($4,125,000)
  15. 4 Open-market sale Director sold 47,536 shares at an average $149.49 ($7,106,341)
  16. 4 Open-market sale Director sold 30,375 shares at an average $152.48 ($4,631,583)
  17. 4 Open-market sale President sold 25,000 shares at $156.55 ($3,913,750)
  18. 4 Open-market sale President sold 25,000 shares at an average $128.62 ($3,215,458)
  19. 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $126.43 ($3,792,804)
  20. 4 Open-market sale Director sold 10,000 shares at an average $126.61 ($1,266,118)

Page 11 of 26 · 502 filings